Why Do You Need a Pacemaker After Valve Replacement?

The heart’s electrical wiring runs remarkably close to its valves, and replacing or implanting a new valve can bruise, stretch, or compress that wiring enough to disrupt the heartbeat. When that disruption is severe or persistent, a pacemaker becomes necessary to keep the heart beating at a safe, steady rhythm. The risk varies widely depending on which valve is treated, how the procedure is performed, and certain features of your individual anatomy, but it is one of the most common complications of valve replacement overall.

How Valve Replacement Damages the Heart’s Electrical System

Your heart has a built-in electrical relay system that coordinates each beat. Signals travel from the upper chambers down through a narrow bundle of specialized fibers that sits in the tissue between the aortic valve and the upper part of the muscular wall separating the two lower chambers. That bundle, and the branches that fan out from it, are only millimeters away from the ring of tissue where a replacement valve gets anchored. During surgery or a catheter-based procedure, the mechanical force of removing the old valve, inflating a balloon, or locking a new frame into place can injure those fibers. The result ranges from a temporary slowdown in electrical conduction to a complete block where signals no longer reach the lower chambers at all.

A complete block means the lower chambers lose their instructions from above and either beat dangerously slowly on their own backup rhythm or, in some cases, pause altogether. That is the scenario where a permanent pacemaker is needed: a small device implanted under the skin that sends electrical pulses to keep the heart rate from dropping too low. Partial blocks sometimes resolve on their own as swelling subsides, but when they persist or progress, implanting a pacemaker is the safest path forward.

How Often It Happens

The odds depend heavily on the type of procedure. For traditional open-heart surgical aortic valve replacement (SAVR) performed alone, roughly 5% of patients end up needing a permanent pacemaker.¹ For transcatheter aortic valve replacement (TAVR), the catheter-based alternative where a new valve is threaded in through a blood vessel, rates have historically been higher. A large comparative study found that about 10% of TAVR patients needed a pacemaker within the first 30 days, compared with roughly 3.5% after surgical replacement.² A systematic review and meta-analysis of trials comparing the two approaches confirmed that pacemaker risk is consistently higher with the catheter-based route.³

The gap narrows over time, though. By five years, the difference between TAVR and surgical replacement shrinks because some surgical patients develop delayed conduction problems of their own. In matched comparisons, late pacemaker implantation beyond 30 days was similar between the two groups.² So TAVR’s higher pacemaker rate is largely an early phenomenon, driven by the way the device is deployed.

Why TAVR Carries a Higher Risk

During TAVR, a compressed valve is guided into position and then expanded inside the old, calcified valve. That expansion applies radial force directly against the surrounding tissue, including the area where the electrical conduction bundle passes. Unlike open surgery, where a surgeon can see the conduction tissue and try to avoid it, the catheter-based approach relies on imaging and careful positioning, but the force of expansion is less precise. The stiffer and more calcified the native valve, the more force gets transmitted to the conduction system.⁴

Research into the specific mechanisms shows that conduction blocks occurring during the procedure itself behave differently from those appearing days later. Blocks that develop during valve deployment tend to be persistent and are strongly predicted by a pre-existing conduction abnormality called right bundle branch block. Delayed blocks, which emerge hours or days afterward, are more often intermittent and appear to result from ongoing tissue swelling or inflammation rather than direct crushing. These delayed blocks have different warning signs, including prolonged conduction intervals measured at the end of the procedure.⁵ An investigation into whether colchicine, an anti-inflammatory drug, could reduce pacemaker rates after TAVR found that it helped with milder conduction problems but made no significant difference for complete heart block, reinforcing the idea that mechanical compression is the dominant cause of the most serious blocks.⁶

The Valve Device Itself Matters

Not all transcatheter valves carry equal pacemaker risk. The two main types are balloon-expandable valves (inflated into place with a balloon) and self-expanding valves (which spring open on their own from a compressed cage). Self-expanding designs exert continuous outward pressure on surrounding tissue as they settle, which pushes harder against the conduction system. A large registry-based analysis found that balloon-expandable technology was associated with lower pacemaker rates both in the first 30 days and over longer follow-up compared with self-expanding valves.⁷

A network meta-analysis including over 40,000 patients put more precise numbers on this. The pooled pacemaker rate was about 19% for balloon-expandable valves, roughly 25% for self-expanding valves, and approximately 35% for a newer category called mechanically expandable valves. Balloon-expandable designs were associated with about 39% lower odds of needing a pacemaker compared with self-expanding ones and 62% lower odds compared with mechanically expandable ones.⁸ In the specific setting of bicuspid aortic valves (where the valve has two leaflets instead of the usual three), balloon-expandable valves again showed a substantially lower risk of pacemaker implantation.⁹

Who Is at Higher Risk

Several patient-specific factors increase the chance of needing a pacemaker. The most powerful predictor is a pre-existing right bundle branch block, a condition where one of the two main branches of the heart’s electrical wiring is already damaged before surgery. In a large multi-center registry, right bundle branch block carried an eightfold increase in the odds of pacemaker implantation after TAVR.¹⁰ First-degree heart block (a milder conduction delay detectable on a standard electrocardiogram) roughly doubled the risk in the same analysis.

Anatomy plays a critical role too. A structure called the membranous septum acts as a thin dividing wall near where the conduction bundle runs. Patients with a shorter membranous septum have less cushion between the valve frame and their electrical wiring. Multiple studies have confirmed that shorter membranous septum length independently predicts conduction problems after TAVR.¹¹ When the implanted valve extends deeper below the valve ring, it overlaps more with this vulnerable zone. Patients whose valves end up sitting deeper have significantly higher rates of conduction block.¹²

For surgical replacement, older age, coexisting medical conditions, and having multiple valves operated on at once are the main risk multipliers. Patients undergoing surgical aortic valve replacement combined with mitral valve replacement had pacemaker rates around 10%, roughly double the rate of aortic valve surgery alone.¹

Tricuspid and Mitral Valve Surgery

Pacemaker risk is not unique to aortic valve procedures. Tricuspid valve surgery, which addresses the valve between the right upper and lower chambers, carries its own substantial risk because the conduction system’s relay point sits right at the edge of the tricuspid valve ring. In one large analysis, nearly 19% of patients undergoing tricuspid valve surgery required a permanent pacemaker, with replacement of the valve carrying more than three times the risk compared with repair.¹³ A high-volume center reported an 11% pacemaker rate across all tricuspid valve operations, with the majority of these patients also having other valves operated on simultaneously.¹⁴

Mitral valve surgery alone has a much lower pacemaker rate. In a study comparing mitral-only operations to mitral plus tricuspid surgery, fewer than 1% of patients who had only mitral work needed a pacemaker, versus about 5.5% of those who had both valves addressed.¹⁵ The risk climbs steeply with the number of valves involved. A 14-year study tracking pacemaker implantation after various combinations of valve surgery found that cumulative pacemaker rates rose from about 4% shortly after surgery to over 14% by ten years for a single aortic valve replacement, and to over 25% by ten years when all three valves were operated on together.¹⁶

Techniques That Are Reducing Pacemaker Rates

As the connection between valve positioning and conduction damage has become clearer, operators have developed implantation techniques specifically aimed at lowering pacemaker rates. Two strategies stand out. The first is a “high implantation” approach, where the valve is deliberately positioned slightly higher (closer to the aorta and farther from the conduction bundle). A study testing this systematic approach with balloon-expandable valves found a substantial reduction in both conduction abnormalities and pacemaker requirements without compromising how well the valve worked.¹⁷

The second is the “cusp overlap” technique, a specific way of angling the imaging camera during deployment of self-expanding valves so the operator can judge implant depth more accurately. A meta-analysis of five trials comparing cusp overlap to the traditional approach found pacemaker rates of about 10% with the newer technique versus roughly 21% with the conventional method, a reduction of more than half.¹⁸ At centers that have refined their technique over time, pacemaker rates with self-expanding valves have fallen dramatically. One center tracked its experience and saw early pacemaker rates drop from about 27% in 2015–2016 to under 6% by 2021 as operators learned to implant the valve shallower.¹⁹

The Waiting Game After the Procedure

Not every conduction problem that appears right after valve replacement sticks around. Some resolve within days as inflammation settles. This creates a dilemma: implant a pacemaker too early and some patients may have gotten one they did not need; wait too long and a dangerous heart block could occur after the patient goes home. One strategy gaining traction is using a temporary-permanent pacemaker as a bridge, a temporary pacing wire left in place for about a month while the team watches whether the conduction block resolves. A multicenter study of this approach found that about 76% of patients who initially seemed to need a pacemaker ultimately did not require permanent implantation, dropping the overall pacemaker rate from over 8% at 48 hours to about 2.5% at one month.²⁰

For patients without obvious complete heart block but with new conduction changes on their electrocardiogram, portable heart monitors worn at home for two to four weeks have become an important safety net. A prospective multicenter study using 14-day continuous monitoring found that about 5% of patients discharged without a pacemaker developed serious heart block afterward, typically around five days post-procedure. Patients with pre-existing right bundle branch block or new conduction disturbances were at the highest risk.²¹ Case reports have also highlighted that even patients who pass a specialized electrical study of the heart in the hospital can still develop dangerous blocks after discharge, underscoring the value of home monitoring.²²

Long-Term Outcomes With a Post-Valve Pacemaker

Getting a pacemaker after valve replacement is not without consequences beyond the extra procedure itself. Data from the large Swiss TAVR registry showed that patients who needed a pacemaker had modestly higher overall and cardiovascular death rates at one, five, and ten years of follow-up, along with higher rates of heart-function decline and worsening symptoms.²³ A meta-analysis pooling over 50,000 TAVR patients found that those who received a pacemaker had about an 18% higher risk of dying over follow-up and a roughly 32% higher rate of hospitalization for heart failure.²⁴

These numbers deserve some context. Patients who develop conduction problems tend to be older, sicker, and have more pre-existing heart disease, so the pacemaker itself is not necessarily the sole cause of the worse outcomes. Still, long-term right-ventricular pacing (where the pacemaker stimulates from a traditional location in the right ventricle) can gradually weaken the heart’s pumping coordination over time, which likely contributes to the heart failure signal in these studies.

Quality-of-life data offer a more reassuring picture. One study found that patients who received a pacemaker after TAVR had lower quality-of-life scores at one month compared with those who did not, but by one year the difference had disappeared.²⁵ A substudy from a large Dutch trial confirmed that pacemakers implanted after TAVR did not significantly reduce quality of life over time when compared with patients who avoided one.²⁶

Newer Pacemaker Technologies for Post-Valve Patients

The type of pacemaker implanted after valve replacement is evolving. Traditional transvenous pacemakers use wires threaded through veins into the heart, which can be tricky in patients who already have a prosthetic valve in place. Two newer approaches are gaining ground.

Leadless pacemakers are tiny, self-contained devices implanted directly inside the heart via catheter, eliminating the need for wires running through the veins. After TAVR, leadless pacemakers have been associated with fewer in-hospital complications and substantially lower rates of device-related problems over the medium term compared with traditional transvenous systems, with no significant difference in death rates or heart failure hospitalization.²⁷ Early experience at individual centers has confirmed that implanting a leadless pacemaker shortly after TAVR is feasible, with shorter procedure times and good pacing performance.²⁸

The other innovation is a pacing approach called left bundle branch area pacing, where the pacing wire is positioned to stimulate the heart’s natural conduction fibers rather than the muscle directly. This aims to produce a more natural pattern of heart contraction, avoiding the desynchronization caused by traditional right-ventricular pacing. In a study of 49 patients who received this type of pacing after TAVR, the abnormally wide electrical signal caused by the valve procedure was significantly narrowed, a biomarker of heart stress dropped over follow-up, and patients with reduced heart function at baseline showed meaningful improvement in their pumping strength.²⁹ Researchers have suggested this approach should be considered the preferred pacing strategy for post-TAVR patients who need a permanent device.³⁰ One important caveat: a case report documented a rare rhythm disturbance directly caused by the deep placement of the pacing wire in the heart wall, a reminder that this technique, while promising, is not risk-free and requires careful patient selection.³¹

Hospital Costs and Recovery

From a practical standpoint, needing a pacemaker after valve surgery adds meaningfully to the hospital stay and the bill. In a U.S. nationwide analysis of surgical aortic valve replacement, patients who required a pacemaker had a median hospital stay of 12 days compared with 9 days for those who did not, and median hospital costs were about $50,000 versus $37,000.¹ Patients were also somewhat less likely to be discharged directly home, often needing a short stay in a rehabilitation facility instead. For TAVR patients, the additional procedure and monitoring similarly extend what is otherwise often a very brief hospitalization. In one study comparing TAVR and surgical patients who received pacemakers, the median time from the valve procedure to pacemaker implantation was about six days for TAVR patients.³² That waiting period, during which the team monitors for spontaneous recovery, adds days that a TAVR patient might otherwise not spend in the hospital.